Fig. 2

MFC-MRD levels at TP1 and TP2.MFC-MRD levels at TP1 and TP2 in the whole cohort (a, d), in relapsed patients (b, e), and in patients who had not relapsed (c, f). MFC, multiparametric flow cytometry; MRD, minimal residual disease; TP1, on days 28–35 after the first induction course; TP2, at the end of the second induction course (before start of consolidation)